This text is a result of machine translation.
Commentary of financial Associated Press: the framework agreement should also be made clear that the letter Phi cannot ambush
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Changes in the aquaculture sector pulled Fucheng shares up by the daily limit
Oil and gas stocks fell at the opening, and many stocks fell by more than 5%
Research
Consumer StaplesChina’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Accelerated shuffle of pig breeding leaders with uneven fat and lean
Nonferrous metal plate strengthened due to shock, and changal shares rose by the limit
Zhengbang technology responded to the overdue non cashing of 500million commercial bills: the company is actively negotiating and communicating with creditors
RNA Biotech Therorna Bags Over CNY 280 Mn in Series A Financing Round
Therorna, specialized in the development of cutting-edge circular RNA technology-based vaccines and therapies, will accelerate the development of a new broad-spectrum COVID-19 vaccine and other product pipelines with the fresh proceeds.
Jun 23, 2022 03:45 PM
Zhengbang Technology: the total amount of equity assets of some feed holding subsidiaries sold to Dabei agriculture is about 2-2.5 billion yuan
Successful Multinational Corporations in China Series: Qualcomm China
Jun 25, 2022 02:02 PM